Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparative Safety and Efficacy of Two Treatments in the Treatment of Inflammatory Lesions of Rosacea

NCT02795117 is registered in ClinicalTrials.gov with Padagis LLC as lead sponsor.

NCT NCT02795117
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02795117 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparative Safety and Efficacy of Two Treatments in the Treatment of Inflammatory Lesions of Rosacea
Lead sponsor
Padagis LLC
Phase
Phase 3
Overall status
Completed
Start date
May 31, 2016
Completion date
February 28, 2017
Enrollment
486 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

rosacea